Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Decide which is better for your needs: credit card points or cash back. Evaluate the benefits to optimize your rewards strategy.
27,103 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Dell Technologies rode a wave of AI server demand to a $33.4 billion quarterly revenue, beating expectations and lift...
With $1,000 in hand, you can explore high-growth artificial intelligence moonshots. This guide breaks down two potent...
Understanding James River (JRVR) earnings means decoding insurance results, investment income, and risk management. T...
LifeStance Health Group stunned the market with a beat-and-raise quarter, sending its stock up roughly 20%. This deep...
From boxed software on shelves to cloud-based subscriptions, software pricing has evolved dramatically. This guide br...
Is Nebius the nebius next amazon? This article digs into Nebius's model, how it stacks up to Amazon, and what it woul...
AST SpaceMobile has surged, leaving investors asking whether spacemobile buy, sell, hold makes sense now. This articl...
AMD posts robust data-center growth and free cash flow gains, while Intel sticks to its turnaround plan with heavy fo...
Bitcoin remains rangebound near the mid-$60,000s as geopolitical tensions rise and expectations for policy easing fad...
A New Jersey family faces nearly $300,000 in student debt against a paid-off $450,000 home and a $107k gross income, ...
Bitcoin slides to a fresh monthly low near $74,000 as bearish momentum returns. Traders weigh moving-average signals,...